NeuroMetrix Statistics
Total Valuation
NeuroMetrix has a market cap or net worth of $7.25 million. The enterprise value is -$10.51 million.
| Market Cap | 7.25M |
| Enterprise Value | -10.51M |
Important Dates
The next estimated earnings date is Wednesday, May 1, 2024, before market open.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NeuroMetrix has 1.99 million shares outstanding. The number of shares has increased by 10.75% in one year.
| Shares Outstanding | 1.99M |
| Shares Change (YoY) | +10.75% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 16.03% |
| Owned by Institutions (%) | 5.68% |
| Float | 1.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.23 |
| Forward PS | n/a |
| PB Ratio | 0.36 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.81, with a Debt / Equity ratio of 0.01.
| Current Ratio | 16.81 |
| Quick Ratio | 14.92 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.30% and return on invested capital (ROIC) is -35.17%.
| Return on Equity (ROE) | -31.30% |
| Return on Assets (ROA) | -29.30% |
| Return on Capital (ROIC) | -35.17% |
| Revenue Per Employee | $226,978 |
| Profits Per Employee | -$251,134 |
| Employee Count | 26 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 1.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.27% in the last 52 weeks. The beta is 2.32, so NeuroMetrix's price volatility has been higher than the market average.
| Beta (1Y) | 2.32 |
| 52-Week Price Change | -68.27% |
| 50-Day Moving Average | 3.72 |
| 200-Day Moving Average | 4.65 |
| Relative Strength Index (RSI) | 45.20 |
| Average Volume (30 Days) | 45,182 |
Short Selling Information
The latest short interest is 11,297, so 0.57% of the outstanding shares have been sold short.
| Short Interest | 11,297 |
| Short Previous Month | 23,214 |
| Short % of Shares Out | 0.57% |
| Short % of Float | 0.68% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, NeuroMetrix had revenue of $5.90 million and -$6.53 million in losses. Loss per share was -$6.27.
| Revenue | 5.90M |
| Gross Profit | 3.95M |
| Operating Income | -7.15M |
| Pretax Income | -6.53M |
| Net Income | -6.53M |
| EBITDA | -6.47M |
| EBIT | -6.53M |
| Loss Per Share | -$6.27 |
Balance Sheet
The company has $18.00 million in cash and $240,876 in debt, giving a net cash position of $17.76 million or $8.94 per share.
| Cash & Cash Equivalents | 18.00M |
| Total Debt | 240,876 |
| Net Cash | 17.76M |
| Net Cash Per Share | $8.94 |
| Equity / Book Value | 20.09M |
| Book Value Per Share | 10.11 |
| Working Capital | 19.61M |
Cash Flow
In the last 12 months, operating cash flow was -$6.08 million and capital expenditures -$183,542, giving a free cash flow of -$6.27 million.
| Operating Cash Flow | -6.08M |
| Capital Expenditures | -183,542 |
| Free Cash Flow | -6.27M |
| FCF Per Share | -$5.84 |
Margins
Gross margin is 66.89%, with operating and profit margins of -121.18% and -110.64%.
| Gross Margin | 66.89% |
| Operating Margin | -121.18% |
| Pretax Margin | -110.64% |
| Profit Margin | -110.64% |
| EBITDA Margin | -109.70% |
| EBIT Margin | -110.64% |
| FCF Margin | -106.22% |
Dividends & Yields
NeuroMetrix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -10.75% |
| Shareholder Yield | -10.75% |
| Earnings Yield | -90.05% |
| FCF Yield | -86.45% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 22, 2023. It was a reverse split with a ratio of 1:8.
| Last Split Date | Nov 22, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
NeuroMetrix has an Altman Z-Score of -10.1 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.1 |
| Piotroski F-Score | 2 |